MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 4 filers reported holding MEDICINES CO in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,567,000 | +95.2% | 30,245 | +15.0% | 0.01% | +66.7% |
| Q3 2019 | $1,315,000 | +742.9% | 26,306 | +370.7% | 0.00% | – |
| Q1 2019 | $156,000 | +2.6% | 5,589 | -29.6% | 0.00% | – |
| Q4 2018 | $152,000 | -58.8% | 7,940 | -35.7% | 0.00% | -100.0% |
| Q3 2018 | $369,000 | -18.5% | 12,351 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $453,000 | +11.3% | 12,351 | -0.0% | 0.00% | 0.0% |
| Q1 2018 | $407,000 | +23.3% | 12,356 | +3.6% | 0.00% | 0.0% |
| Q4 2017 | $330,000 | -25.3% | 11,930 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $442,000 | 0.0% | 11,930 | +2.5% | 0.00% | 0.0% |
| Q2 2017 | $442,000 | -60.9% | 11,640 | -49.6% | 0.00% | -50.0% |
| Q1 2017 | $1,130,000 | +236.3% | 23,115 | +134.0% | 0.00% | +100.0% |
| Q4 2016 | $336,000 | – | 9,878 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |